FundedIQ
Biotechnology

Vera Therapeutics: Funding, Investors & Team (Oct 2026)

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential. The company's gene-editing technology can potentially cure patients with sickle cell disease, cystic fibrosis, and other devastating genetic disorders, enabling physicians to improve gene detection and regulation.

veratx.com LinkedIn South San Francisco, United States 11-50 employees
Total raised
$826M
Rounds
5
Latest
Undisclosed round
Dec 2025

Vera Therapeutics has raised $826M across 5 funding rounds on record, the most recent an undisclosed round of $261M announced in Dec 2025.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Vera Therapeutics Company Profile and Key Stats

Total funding raised
$826M
across 5 rounds on record
Funding rounds on record
5
Latest funding round
Undisclosed round
$261M in Dec 2025
Employees
11-50
reported band
Headquarters
South San Francisco, United States

Latest funding round on record: Dec 2025.

Vera Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
$261M
Undisclosed round
$75.0M
Undisclosed round
$300M
Undisclosed round
$115M
Post-IPO Equity
$74.9M

Vera Therapeutics raised $74.9M in a Post-IPO Equity announced in Feb 2022.

1 years later, an undisclosed round of $115M was announced in Feb 2023.

1.7 years later, an undisclosed round of $300M was announced in Oct 2024.

8 months later, an undisclosed round of $75.0M was announced in Jun 2025.

6 months later, an undisclosed round of $261M was announced in Dec 2025.

Vera Therapeutics Founders and Leadership Team

Name
Role
Contact
Marshall Fordyce
Founder
Locked

Contact details for the Vera Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Vera Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Vera Therapeutics' latest round of $261M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Vera Therapeutics in Biotechnology and South San Francisco

Companies Similar to Vera Therapeutics

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Vera Therapeutics Funding FAQs

What does Vera Therapeutics do?

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential. The company's gene-editing technology can potentially cure patients with sickle cell disease, cystic fibrosis, and other devastating genetic disorders, enabling physicians to improve gene detection and regulation.

How much funding has Vera Therapeutics raised?

Vera Therapeutics has raised $826M across 5 rounds on record. The most recent is an undisclosed round of $261M announced in Dec 2025.

When did Vera Therapeutics last raise funding?

Vera Therapeutics' most recent funding round on record is an undisclosed round of $261M, announced in Dec 2025.

Who founded Vera Therapeutics?

FundedIQ lists Marshall Fordyce (Founder) at Vera Therapeutics.

Where is Vera Therapeutics headquartered?

Vera Therapeutics is based in South San Francisco, California, United States.

How many employees does Vera Therapeutics have?

Vera Therapeutics is in the 11-50 employee band.

How does Vera Therapeutics' funding compare to other Biotechnology startups?

Vera Therapeutics' latest round of $261M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Vera Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vera Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.